Brain health demand SPARK Neuro aims to standardize brain health assessments in care, addressing a large undiagnosed dementia population. Sales opportunity: position SPARK as a scalable cognitive screening solution for health systems and payers to improve early detection and care pathways.

FDA‑cleared AI The EEG-based brain scan is FDA‑cleared and AI-enabled, offering a credible, compliant tool. Sales angle: emphasize regulatory clearance and advanced analytics to reduce clinical uncertainty and streamline adoption by hospitals and insurers.

Prestigious collaborations Partnerships with Mayo Clinic and Johns Hopkins Medicine demonstrate credibility and validation in complex clinical environments. Sales tactic: leverage these associations to open pilots and co‑marketing with large health systems and academic centers.

Diversified funding Funding from DoD and NIH signals strong government and research interest in neurotech. Sales angle: pursue opportunities with government contractors, research initiatives, and payers seeking funded pilots or outcomes-based programs.

Market positioning Operating with a small team in healthcare tech and revenue in the 10–25M range with peers in neuro analytics. Sales insight: target mid‑ to large‑size health systems and enterprise payers seeking scalable, non‑invasive brain health assessments to expand service lines and improve dementia care management.